Data governance fundamentals
When ICH revised E6 to create the R3 version, the drafting committee made a deliberate decision: data governance needed its own section. This was not merely organizational housekeeping. It reflected a recognition that clinical trial data have become more complex, more distributed, and more vulnerable to integrity failures than when E6(R2) was written. The proliferation of electronic data capture, central laboratory systems, wearable devices, and multi-source data flows had outpaced the guidance framework.
Section 4 of ICH E6(R3) responds to this reality. It establishes requirements that span the entire data lifecycle—from initial capture through correction, transfer, and eventual destruction. Unlike Section 2.12, which focused on record-keeping at the investigator site, Section 4 addresses data governance as a shared responsibility between sponsors and investigators. While Section 4.3 addresses computerized systems specifically, the broader Section 4 framework focuses on the data themselves rather than the systems that process them.
In my experience teaching GCP over three decades, I have observed that data problems rarely stem from a single point of failure. They emerge from gaps between responsibilities—where the sponsor assumes the site is managing something, and the site assumes the sponsor is handling it. Section 4 closes those gaps by making obligations explicit for both parties.
This lesson examines Section 4 in depth, focusing on how its requirements translate into daily practice for clinical research professionals.